An Open Label, Balanced, Randomized, Two-treatment, Single-dose, Crossover, Bioequivalence Study of Divalproex Sodium Coated Particles in Capsules, 125 mg With Depakote Sprinkle 125 mg in Healthy Human Subjects Under Fasting Conditions.
Phase of Trial: Phase I
Latest Information Update: 29 May 2010
At a glance
- Drugs Valproate semisodium (Primary)
- Indications Bipolar disorders; Epilepsy; Migraine
- Focus Pharmacokinetics
- 30 Jan 2010 New trial record